| Dificid (fidaxomicin) / Merck (MSD), Astellas |
| Completed | 4 | 308 | US | Fidaxomicin, Vancomycin with Taper/Pulse, Vancomycin | VA Office of Research and Development | Clostridium, Difficile, Fidaxomicin, Vancomycin | 08/24 | 08/24 | | |
2020-004591-17: A phase III clinical trial in patients with recurrent Clostridioides difficile (CD) infection, to evaluate the treatment with capsules of lyophilised faecal microbiota vs fidaxomicin Ensayo clínico fase III en pacientes con infección recurrente por Clostridioides difficile (CD) para evaluar el tratamiento con cápsulas de microbiota fecal vs fidaxomicina |
|
|
| Not yet recruiting | 3 | 98 | Europe | MBK-01, Capsule, Film-coated tablet, Dificlir | Mikrobiomik Healthcare Company S.L., Mikrobiomik | Recurrent Clostridioides difficile (CD) infection Infección recurrente por Clostridioides difficile, Recurrent Clostridioides difficile (CD) infection Infección recurrente por Clostridioides difficile, Diseases [C] - Bacterial Infections and Mycoses [C01] | | | | |
NCT05201079: Primary or Recurrent Clostridioides Difficile Infection Treatment With Capsules of Lyophilised Faecal Microbiota vs Fidaxomicin |
|
|
| Completed | 3 | 93 | Europe | MBK-01, Fecal microbiota transfer, Dificlir, Fidaxomicin | Mikrobiomik Healthcare Company S.L. | Recurrent Clostridium Difficile Infection, Primary Clostridium Difficile Infection | 11/23 | 11/23 | | |
FENDER, NCT05266807: Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence |
|
|
| Recruiting | 3 | 220 | Europe | oral capsulized Fecal Microbiota Transplantation, Vancomycin or Fidaxomicin | Benoit Guery | Clostridioides Difficile Infection | 01/25 | 12/25 | | |
2015-003004-24: Faecal microbiota transplantation for relapsing Clostridium difficile infection Fækal mikrobiota transplantation ved recidiv Clostridium difficile infektion |
|
|
| Ongoing | 2 | 64 | Europe | Capsule, Tablet, Vancomycin, Dificlir (fidaxomicin) | Aarhus University Hospital, Regionernes Medicinpulje | Relapsing Clostridium difficile infection Gentagen Clostridium difficile infektion, Relapsing Clostridium difficile infection Gentagen Clostridium difficile infektion, Diseases [C] - Digestive System Diseases [C06] | | | | |
NCT04070352: Evaluation of Fidaxomicin in the Treatment of Clostridium Difficile Infection (CDI) |
|
|
| Withdrawn | N/A | 50 | US | Fidaxomicin, clostridium difficile infection | University of Pittsburgh, Merck Sharp & Dohme LLC | Clostridium Difficile Infection (CDI) | 05/23 | 05/23 | | |
